About: Helen Hobbs

An Entity of Type: person, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Helen Haskell Hobbs, M.D., (born May 5, 1952 in Boston, Massachusetts) is a professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2018 Harrington Prize for Innovation in Medicine. She and Jonathan C. Cohen found that people with hypomorphic PCSK9 mutations had lower LDL-cholesterol levels and were almost immune to heart disease. This finding led to the development of a new class of cholesterol-lowering drugs that mimic the effects of the PCSK9 mutations. She and Jonathan Cohen also identified the first genetic risk factor for fatty liver disease, a burgeoning health problem that can lead to cirrhosis and liver cancer. Their laboratory has shown that mutation in PNPLA3

Property Value
dbo:abstract
  • هيلين هوبز (بالإنجليزية: Helen Hobbs)‏ هي عالمة كيمياء حيوية وأستاذة جامعية وطبيبة أمريكية، ولدت في 5 مايو 1952 في بوسطن في الولايات المتحدة. (ar)
  • Helen Haskell Hobbs (* 5. Mai 1952 in Boston, Massachusetts) ist eine US-amerikanische Genetikerin und Stoffwechselforscherin am in Dallas. Sie gilt als führend in der Genetik der Hypercholesterinämie und Dyslipoproteinämie. (de)
  • Helen Haskell Hobbs, M.D., (born May 5, 1952 in Boston, Massachusetts) is a professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2018 Harrington Prize for Innovation in Medicine. She and Jonathan C. Cohen found that people with hypomorphic PCSK9 mutations had lower LDL-cholesterol levels and were almost immune to heart disease. This finding led to the development of a new class of cholesterol-lowering drugs that mimic the effects of the PCSK9 mutations. She and Jonathan Cohen also identified the first genetic risk factor for fatty liver disease, a burgeoning health problem that can lead to cirrhosis and liver cancer. Their laboratory has shown that mutation in PNPLA3 causes accumulation of PNPLA3 on lipid droplets, which compromises the mobilization of triglycerides from liver cells. She sits on the Board of Directors at Pfizer. (en)
  • Helen Hobbs, née en 1952, est une biologiste moléculaire et généticienne américaine. Elle est professeure et directrice de recherche à l'École médicale du Sud-Ouest de l'université du Texas et au Howard Hughes Medical Institute. En 2016, elle a reçu le Breakthrough Prize in Life Sciences pour la découverte de variantes génétiques, qui modifient les niveaux et la distribution du cholestérol et autres lipides dans le corps humain. Cela a inspiré de nouvelles approches dans la prévention des maladies cardiovasculaires et des maladies du foie. (fr)
  • Хелен Хоббс (Helen Haskell Hobbs; род. 5 мая 1952, Бостон, Массачусетс) — американский учёный-медик, генетик.Профессор и исследователь Медицинского института Говарда Хьюза, член Национальных Академии наук (2007) и (2004) США. (ru)
  • Helen Hobbs é uma médica estadunidense. É professora da University of Texas Southwestern Medical Center, e pesquisadora do Instituto Médico Howard Hughes. Recebeu o Breakthrough Prize in Life Sciences de 2016. (pt)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 48504761 (xsd:integer)
dbo:wikiPageLength
  • 6729 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1117402625 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
schema:sameAs
rdf:type
rdfs:comment
  • هيلين هوبز (بالإنجليزية: Helen Hobbs)‏ هي عالمة كيمياء حيوية وأستاذة جامعية وطبيبة أمريكية، ولدت في 5 مايو 1952 في بوسطن في الولايات المتحدة. (ar)
  • Helen Haskell Hobbs (* 5. Mai 1952 in Boston, Massachusetts) ist eine US-amerikanische Genetikerin und Stoffwechselforscherin am in Dallas. Sie gilt als führend in der Genetik der Hypercholesterinämie und Dyslipoproteinämie. (de)
  • Helen Hobbs, née en 1952, est une biologiste moléculaire et généticienne américaine. Elle est professeure et directrice de recherche à l'École médicale du Sud-Ouest de l'université du Texas et au Howard Hughes Medical Institute. En 2016, elle a reçu le Breakthrough Prize in Life Sciences pour la découverte de variantes génétiques, qui modifient les niveaux et la distribution du cholestérol et autres lipides dans le corps humain. Cela a inspiré de nouvelles approches dans la prévention des maladies cardiovasculaires et des maladies du foie. (fr)
  • Хелен Хоббс (Helen Haskell Hobbs; род. 5 мая 1952, Бостон, Массачусетс) — американский учёный-медик, генетик.Профессор и исследователь Медицинского института Говарда Хьюза, член Национальных Академии наук (2007) и (2004) США. (ru)
  • Helen Hobbs é uma médica estadunidense. É professora da University of Texas Southwestern Medical Center, e pesquisadora do Instituto Médico Howard Hughes. Recebeu o Breakthrough Prize in Life Sciences de 2016. (pt)
  • Helen Haskell Hobbs, M.D., (born May 5, 1952 in Boston, Massachusetts) is a professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute Investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2018 Harrington Prize for Innovation in Medicine. She and Jonathan C. Cohen found that people with hypomorphic PCSK9 mutations had lower LDL-cholesterol levels and were almost immune to heart disease. This finding led to the development of a new class of cholesterol-lowering drugs that mimic the effects of the PCSK9 mutations. She and Jonathan Cohen also identified the first genetic risk factor for fatty liver disease, a burgeoning health problem that can lead to cirrhosis and liver cancer. Their laboratory has shown that mutation in PNPLA3 (en)
rdfs:label
  • هيلين هوبز (ar)
  • Helen Hobbs (de)
  • Helen Hobbs (fr)
  • Helen Hobbs (en)
  • Helen Hobbs (pt)
  • Хоббс, Хелен (ru)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License